Abstract 5769: Disparities in uptake of levonorgestrel-releasing intrauterine system (LNG-IUS): implications for uterine cancer primary prevention
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-5769
Abstract: Introduction: Levonorgestrel-releasing intrauterine system (LNG-IUS) is associated with ~50% risk reduction for uterine cancer incidence and can be an effective primary prevention strategy. We aimed to understand current patterns of LNG-IUS use and identify disparities… read more here.
Keywords: uterine cancer; lng ius; ius use; ref ... See more keywords
Use Patterns of Levonorgestrel-Releasing Intrauterine System among American Women.
Sign Up to like & getrecommendations! Published in 2025 at "Cancer prevention research"
DOI: 10.1158/1940-6207.capr-24-0302
Abstract: Levonorgestrel-releasing intrauterine system (LNG-IUS) use is approved by the FDA for contraception and heavy menorrhagia. More importantly, it effectively treats endometrial hyperplasia, a precursor to endometrial cancer. Thereby, LNG-IUS use is associated with potential endometrial… read more here.
Keywords: use; ius use; levonorgestrel releasing; releasing intrauterine ... See more keywords